Clover May

London UK

Contact Me Today

Clover is an associate in the Emerging Companies and M&A team in London. She specialises in advising companies and investors in the technology and life science sectors on venture capital investments, M&A transactions and general corporate matters.

Clover's news & insights

View Clover's insights

Click here to find out more

Life sciences & healthcare

Advising on Tropic Biosciences' US$105 million Series C financing

25 March 2026

by multiple authors

Employment, pensions & mobility

New legislation governing Allocation of Tips to come into force in July 2024

21 March 2024

Quick read

by Clover May

Click here to find out more

Employee incentives

Lexology Executive Compensation & Employee Benefits 2023 - UK chapter

14 November 2023

by multiple authors

Click here to find out more

Clover May

Expertise

Services and Groups

Sectors

Clover's news & insights

Advising on Tropic Biosciences' US$105 million Series C financing

Clover May

Expertise

Services and Groups

Sectors

Clover's news & insights

Advising on Tropic Biosciences' US$105 million Series C financing

Related news & insights

#7: State of the EU Crypto Industry: MiCA, Tokenisation and What Comes Next

Online coaching and distance learning: Federal Court of Justice clarifies application of the Distance Learning Protection Act

Proposed Amendments to the EU Medical Device Regulation

Impact of the new Biotech Act on Clinical Trials in the EU

The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU

Advising Eurofins on the sale of its electrical and electronic testing business for EUR575 million

Advising on Sona's US$45 million Series B funding

Life Sciences Legal Lens – Vol. 1

Taylor Wessing strengthens Corporate/M&A practice with Equity Partner Jan Hückel

Hungary opens health data infrastructure for AI development

Related people

Meet me at